AKT1 and prostate cancer: Studies have shown that EGCG can prevent the proliferation of prostate cancer cells and breast cancer cells by modulating the protein kinase B (Akt)/phosphatidylinositide 3-kinases (PI3K) signaling pathway, which participates in the transcriptional regulation of many genes related to cancer cell proliferation [31,56].